Literature DB >> 20103453

Feasibility of telephone follow-up after medical abortion.

Lisa K Perriera1, Matthew F Reeves, Beatrice A Chen, Heather L Hohmann, Jennifer Hayes, Mitchell D Creinin.   

Abstract

BACKGROUND: This study was conducted to assess the feasibility of using telephone calls combined with high-sensitivity urine pregnancy testing as a primary method of follow-up after medical abortion.
METHODS: We enrolled 139 women up to 63 days of gestation to receive mifepristone 200 mg orally and misoprostol 800 mcg vaginally or buccally, per their choice. Participants were contacted by phone one week after mifepristone administration and interviewed using standardized questions. If the subject or clinician thought the pregnancy was not expelled, the subject returned for an ultrasound examination. Otherwise, subjects performed high-sensitivity home urine pregnancy testing 30 days after the mifepristone and were called within 3 days of the test. Those with positive pregnancy tests returned for an ultrasound examination. Those with negative tests required no further follow-up.
RESULTS: Six of the 139 (4.3%, 95% CI 1.6-9.1%) subjects presented prior to Phone Call 1 for an in-person visit. All 133 (100%, 95% CI 97.8-100%) subjects eligible for their first telephone follow-up were contacted. Eight of the 133 (6.1%, 95% CI 2.6-11.5%) women were asked to return for evaluation and all did so (100%, 95% CI 63.1-100%). Eight of the 133 women eligible for the 30 day phone call presented for an interim visit prior to the call. After 30 days, 116 of the 117 (99.1%, 95% CI 97.5-100%) eligible subjects were contacted. One subject was not reached for the day 30 phone call. Twenty-seven of the 116 (23.3%, 95% CI 15.6-31.0%) subjects had a positive pregnancy test and required follow-up. Two of these subjects (7.4%, 95% CI 1.0-24.2%) did not return for in-person follow-up. Two of the 116 (1.7%, 95% CI 0.2-6.1%) subjects had inconclusive pregnancy tests and were asked to return for follow-up. One of these subjects (50%, 95% CI 1.2-98.7%) did not return. Complete follow-up was achieved in 135 of the 139 subjects (97.1%, 95% CI 94.3-99.9%). None of the 26 women evaluated for a positive or inconclusive pregnancy test had a gestational sac or continuing pregnancy.
CONCLUSION: Telephone follow-up combined with urine pregnancy testing after medical abortion is a feasible alternative to routine ultrasonography or serial serum hCG measurements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20103453     DOI: 10.1016/j.contraception.2009.08.008

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  16 in total

1.  Management of first trimester pregnancy loss can be safely moved into the office.

Authors:  Jana L Allison; Rebecca S Sherwood; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2011

2.  Progestin-based contraceptive on the same day as medical abortion.

Authors:  Jeanna Park; Nuriya Robinson; Ursula Wessels; James Turner; Stacie Geller
Journal:  Int J Gynaecol Obstet       Date:  2016-01-06       Impact factor: 3.561

3.  Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.

Authors:  Mandira Paul; Kirti Iyengar; Sharad Iyengar; Kristina Gemzell-Danielsson; Birgitta Essén; Marie Klingberg-Allvin
Journal:  BMC Womens Health       Date:  2014-08-15       Impact factor: 2.809

4.  Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.

Authors:  Rasha Dabash; Tara Shochet; Selma Hajri; Héla Chelli; Anne-Emmanuele Hassairi; Douha Haleb; Hayet Labassi; Ezzedine Sfar; Fatma Temimi; Leah Koenig; Beverly Winikoff
Journal:  BMC Womens Health       Date:  2016-07-30       Impact factor: 2.809

5.  A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study.

Authors:  Daniel Grossman; Sarah E Baum; Denitza Andjelic; Carrie Tatum; Guadalupe Torres; Liza Fuentes; Jennifer Friedman
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

6.  Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.

Authors:  Mette Løkeland; Tone Bjørge; Ole-Erik Iversen; Rupali Akerkar; Line Bjørge
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

Review 7.  A research agenda for moving early medical pregnancy termination over the counter.

Authors:  N Kapp; D Grossman; E Jackson; L Castleman; D Brahmi
Journal:  BJOG       Date:  2017-04-27       Impact factor: 6.531

8.  Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.

Authors:  Ellen R Wiebe; Mackenzie Campbell; Harani Ramasamy; Michaela Kelly
Journal:  Contracept X       Date:  2020-04-11

9.  Integrating mobile phones into medical abortion provision: intervention development, use, and lessons learned from a randomized controlled trial.

Authors:  Katherine Marianne de Tolly; Deborah Constant
Journal:  JMIR Mhealth Uhealth       Date:  2014-02-14       Impact factor: 4.773

10.  Determination of medical abortion success by women and community health volunteers in Nepal using a symptom checklist.

Authors:  Kathryn L Andersen; Mary Fjerstad; Indira Basnett; Shailes Neupane; Valerie Acre; Sharad Sharma; Emily Jackson
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-11       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.